Literature DB >> 23165785

Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011).

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23165785     DOI： 10.1253/circj.cj-66-0053

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  28 in total

1.  Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design.

Authors:  Akihiko Shimizu; Takeshi Mitsuhashi; Takashi Nitta; Hideo Mitamura; Takashi Kurita; Haruhiko Abe; Yuji Nakazato; Naokata Sumitomo; Kazushige Kadota; Kazuo Kimura; Ken Okumura
Journal:  J Arrhythm       Date:  2014-09-12

2.  Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.

Authors:  Manaka Tagaya; Daiji Yoshikawa; Yoshinori Sugishita; Fumi Yamauchi; Takehiro Ito; Tomohito Kamada; Masataka Yoshinaga; Daisuke Mukaide; Wakaya Fujiwara; Hiroatsu Yokoi; Mutsuharu Hayashi; Eiichi Watanabe; Junichi Ishii; Yukio Ozaki; Hideo Izawa
Journal:  Heart Vessels       Date:  2015-05-29       Impact factor: 2.037

3.  Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.

Authors:  Michiyo Shiiba; Bo Zhang; Shin-Ichiro Miura; Amane Ike; Daisuke Nose; Takashi Kuwano; Satoshi Imaizumi; Makoto Sugihara; Atushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Kazuyuki Shirai; Shin'ichiro Yasunaga; Keijiro Saku
Journal:  Heart Vessels       Date:  2017-08-16       Impact factor: 2.037

4.  Are beta blockers still necessary for all survivors of acute myocardial infarction?

Authors:  Daisaku Nakatani; Yasuhiko Sakata
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

5.  Angiotensin Type 1 Receptor Blockers in Heart Failure.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  Curr Drug Targets       Date:  2020       Impact factor: 3.465

6.  Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society.

Authors:  Eiichi Araki; Atsushi Tanaka; Nobuya Inagaki; Hiroshi Ito; Kohjiro Ueki; Toyoaki Murohara; Kenjiro Imai; Masataka Sata; Takehiro Sugiyama; Hideki Ishii; Shunsuke Yamane; Takashi Kadowaki; Issei Komuro; Koichi Node
Journal:  Diabetol Int       Date:  2020-11-30

7.  Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis.

Authors:  Hirokazu Konishi; Katsumi Miyauchi; Takatoshi Kasai; Shuta Tsuboi; Manabu Ogita; Ryo Naito; Yuji Nishizaki; Iwao Okai; Hiroshi Tamura; Shinya Okazaki; Kikuo Isoda; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2015-01-09       Impact factor: 2.037

8.  Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.

Authors:  Mojgan Hajahmadi Pourrafsanjani; Ebrahim Khayati Shal; Sina Khezrpour
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-01-25

9.  Influence of sleep-disordered breathing assessed by pulse oximetry on long-term clinical outcomes in patients who underwent percutaneous coronary intervention.

Authors:  Shoichiro Yatsu; Ryo Naito; Takatoshi Kasai; Hiroki Matsumoto; Jun Shitara; Megumi Shimizu; Azusa Murata; Takao Kato; Shoko Suda; Masaru Hiki; Eiryu Sai; Katsumi Miyauchi; Hiroyuki Daida
Journal:  Clin Res Cardiol       Date:  2018-03-31       Impact factor: 5.460

10.  Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.

Authors:  Motoki Yamashita; Atsushi Iwata; Yuta Kato; Makito Futami; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Heart Vessels       Date:  2018-04-25       Impact factor: 2.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.